Krystal Biotech Overview
Krystal Biotech Target Price
See Krystal Biotech's analyst price targets ($380) vs the current share price.
Get informed when a big investor buys or sells
+ FollowShare Price
$328.34
Average Target Price
$378.33
15.2% upside
15.2% upside3 analysts in the last 4 months
High: $474 | Low: $300
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-13 | Jefferies | $474 | 44.4% upside |  |
| 2026-06-16 | H.C. WainwrightJoseph Pantginis | $361 | 9.9% upside | |
| 2026-05-05 | Evercore ISI | $300 |  8.6% downside | |
| 2026-02-18 | Chardan CapitalGeulah Livshits | $323 | 1.6% downside | |
| 2026-02-17 | JefferiesRoger Song | $371 | 13% upside | |
| 2026-01-30 | Goldman Sachs | $327 | 0.4% downside | |
| 2026-01-09 | H.C. Wainwright | $310 | 5.6% downside | |
| 2025-10-17 | GuggenheimDebjit Chattopadhyay | $224 | 31.8% downside | |
| 2025-08-22 | Chardan Capital | $216 | 34.2% downside | |
| 2024-09-11 | Stifel NicolausDae Gon Ha | $220 | 33% downside | |
| 2024-09-02 | Bank of America SecuritiesAlec Stranahan | $205 | 37.6% downside | |
| 2024-08-12 | Evercore ISIGavin Clark-Gartner | $206 | 37.3% downside | |
| 2024-04-15 | Stifel NicolausDae Gon Ha | $204 | 37.9% downside | |
| 2022-11-07 | Chardan CapitalGeulah Livshits | $133 | 59.5% downside | |
| 2022-08-08 | Chardan CapitalGeulah Livshits | $130 | 60.4% downside | |